Exclusivity of Pfizer's Celebrex Extended to 2015
Pfizer said the U.S. Patent and Trademark Office reissued a patent on the active ingredient in Celebrex, extending the painkiller's exclusivity to 2015 from 2014.
Tags:
Exclusivity of Pfizer's Celebrex Extended to 2015,
Pfizer Latest News